Imagine Eyes launched a new demo showcasing adaptive optics for early detection of retinal cell loss.

Retinal diseases cause visual disability and blindness in over 400 million people worldwide. Imagine Eyes' mission is to enhance the diagnosis and management of these sight-threatening diseases, and improve visual health throughout the world. To do so, the company offers medical imaging devices that detect earlier signs of pathology at the back of the eye, deliver quicker readouts of treatment effectiveness, and enable more personalized retinal therapies. Imagine Eyes' products combine advanced biophotonics imaging with adaptive optics, a breakthrough technology derived from the area of astrophysics. As a result, they deliver images with microscopic resolution, and doctors can examine patients' retinas with an unprecedented level of detail: the cellular level. With Imagine Eyes’ devices, the eye becomes a clear window to health. The company’s team collaborates with several medical centers in order to address clinical applications not only in retinal ophthalmology, but also in other disciplines including cardiology and neurology. Get in touch with Imagine Eyes' team via linkedin or this web page: https://www.imagine-eyes.com/contact/